Changes in the levels of nerve growth factor and middle molecular mass molecules in patients with post-traumatic neuropathies and plexopathies accompanied by chronic neuropathic pain
Wiadomości Lekarskie · 2026
DOI: 10.36740/wlek/222252 ↗Kurz gefasst
Fachartikel in der Zeitschrift Wiadomości Lekarskie, 2026. Verfasst von Tetyana A Litovchenko und 6 weiteren Autor:innen. Beteiligte Einrichtung: KHARKIV NATIONAL MEDICAL UNIVERSITY, KHARKIV, UKRAINE. Hauptthemen laut MEDLINE: Neuralgia, Nerve Growth Factor, Chronic Pain.
Abstract (Originalsprache)
Aim
To investigate and compare the levels of the beta-subunit of NGF (Beta-NGF) and middle molecular mass molecules (MMM) in the blood of patients with post-traumatic non-firearm and firearm neuropathies and plexopathies accompanied by chronic neuropathic pain. Material and methods We examined 93 men aged 21-59 years with compression-ischemic (groupI - comparison), post-traumatic non-firearm (groupII) and firearm (groupIII) neuropathies and plexopathies with and without chronic neuropathic pain syndrome. Quantitative determination of Веtа-NGF in serum was performed by enzyme-linked immunosorbent assay. The content of MMM was determined by spectrophotometric method (fractions MMM238, MMM254, MMM260, MMM280). The following integral indices were calculated: peptide-nucleotide ratio, distribution coefficient, aromaticity coefficient.
Results
We revealed an increased level of Beta-NGF in the blood serum of patients with post-traumatic firearm and non-firearm neuropathies and plexopathies accompanied by chronic neuropathic pain (Mann-WhitneyU-test,p=0.0077 and Mann-WhitneyU-test,p=0.04608, respectively). The level of the CR280/254 in patients of groupIII with post-traumatic firearm neuropathies and plexopathies at a statistically significant level depends on the presence of chronic neuropathic pain (Mann-WhitneyU-test,p=0.0113). The accumulation of biologically active molecules involved in the activation of compensatory, protective mechanisms in patients with post-traumatic firearm neuropathies and plexopathies accompanied by chronic neuropathic pain was established.
Conclusions
The results confirm the existing data on the pathophysiological role of Beta-NGF and MMM in the development of chronic neuropathic pain and indicate the potential use of NGF as a therapeutic target, while the CR280/254 ratio may serve as a biomarker reflecting the accumulation of biologically active molecules associated with chronic neuropathic pain in patients with post-traumatic neuropathies and plexopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- KHARKIV NATIONAL MEDICAL UNIVERSITY, KHARKIV, UKRAINE.
Zitieren
APA
Litovchenko, T. A., Borodai, O., Bondar, O. B., Voitiuk, A., Florikian, V., Zavalna, O., & Lytovchenko, V. (2026). Changes in the levels of nerve growth factor and middle molecular mass molecules in patients with post-traumatic neuropathies and plexopathies accompanied by chronic neuropathic pain. Wiadomości Lekarskie. https://doi.org/10.36740/wlek/222252
Vancouver
Litovchenko TA, Borodai O, Bondar OB, Voitiuk A, Florikian V, Zavalna O, et al. Changes in the levels of nerve growth factor and middle molecular mass molecules in patients with post-traumatic neuropathies and plexopathies accompanied by chronic neuropathic pain. Wiadomości Lekarskie. 2026. doi:10.36740/wlek/222252
BibTeX
@article{Litovchenko2026,
author = {Litovchenko, Tetyana A and Borodai, Olena and Bondar, Oksana B and Voitiuk, Anna and Florikian, Vartanush and Zavalna, Olena and Lytovchenko, Viktor},
title = {Changes in the levels of nerve growth factor and middle molecular mass molecules in patients with post-traumatic neuropathies and plexopathies accompanied by chronic neuropathic pain},
journal = {Wiadomości Lekarskie},
year = {2026},
doi = {10.36740/wlek/222252}
}
EUVIMED